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faecal pathogens and antibiotic residues
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Pathogens and antibiotics enter the aquatic environment via sewage efﬂuents and may pose a health risk to wild life and humans.
The aim of this study was to determine the levels of faecal bacteria, and selected antibiotic residues in raw wastewater and treated
sewage efﬂuents from three different sewage treatment plants in the Western Cape, South Africa. Sewage treatment plant 1 and 2 use
older technologies, while sewage treatment plant 3 has been upgraded and membrane technologies were incorporated in the treatment
processes. Coliforms and Escherichia coli (E. coli) were used as bioindicators for faecal bacteria. A chromogenic test was used to
screenfor coliforms and E. coli.Fluoroquinolones and sulfamethoxazole are commonly used antibiotics and were selectedto monitor
the efﬁciency of sewage treatment processes for antibiotic removal. Enzyme Linked Immunosorbent Assays (ELISAs) were used to
quantitateantibioticresiduesinrawandtreatedsewage.RawintakewateratalltreatmentplantscontainedtotalcoliformsandE.coli.
High removal of E. coli by treatment processes was evident for treatment plant 2 and 3 only. Fluoroquinolones and sulfamethoxazole
were detected in raw wastewater from all sewage treatment plants. Treatment processes at plant 1 did not reduce the ﬂuoroquinolone
concentration in treated sewage efﬂuents. Treatment processes at plant 2 and 3 reduced the ﬂuoroquinolone concentration by 21%
and 31%, respectively. Treatment processes at plant 1 did not reduce the sulfamethoxazole concentration in treated sewage efﬂuents.
Treatment processes at plant 2 and 3 reduced sulfamethoxazole by 34% and 56%, respectively. This study showed that bacteria and
antibiotic residues are still discharged into the environment. Further research needs to be undertaken to improve sewage treatment
technologies, thereby producing a better quality treated sewage efﬂuent.
Keywords:Pathogens,antibiotics,Escherichiacoli,coliforms,ﬂuoroquinolone,sulfamethoxazole,chromogenicassay,EnzymeLinked
Immunosorbent Assay.
Introduction
Faecal contaminants enter environmental water via vari-
ous routes. Non-human faecal contamination can occur by
domestic animals such as dogs and cats.[1] Other signiﬁcant
sourcesoffaecalcontaminationtoenvironmentalwaterare
via rats, beavers, gulls, waterfowl and pigeons.[2]
Humans and other warm-blooded animals have col-
iforms as intestinal ﬂora. These coliforms are excreted and
are discharged to be treated by municipal sewage treatment
plants. However, if the wastewater remains untreated, bac-
terial pathogens present in the sewage efﬂuents can result
in diseases such as dysentery, typhoid, and gastroenteritis
upon exposure to the contaminated water.[3]
Inefﬁcient treatment processes result in microorganisms
being released with treated efﬂuents in the aquatic environ-
ment.[4] The efﬂuents then enter aquatic ecosystems and
become a major source of faecal contamination. Faecal
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contaminants pose a health risk to humans and animals
upon exposure to contaminated water.[4] Monitoring fae-
cal contamination of sewage could provide valuable infor-
mation on urban land uses and potential routes of faecal
contamination.[1,5] Indicator organisms to monitor bacte-
riological quality of water include Escherichia coli (E. coli)
and coliforms.[6]
Variousmethodscanbeemployedtoexaminefaecalcon-
tamination of water sources. The classical methods used to
screen faecal contaminants include the multiple-tube fer-
mentation (MTF) technique and the membrane ﬁlter tech-
nique (MFT). Brieﬂy, the MTF technique is carried out
using different dilutions of the water sample in test tubes.
After 48 hours of incubation, gas production, acid forma-
tion and growth of organisms can then be determined. A
conﬁrmatory test for the target organisms then follows a
presumptive positive reaction.[6] On the other hand, the
MFT technique consists of ﬁltering a water sample using a
sterile ﬁlter (0.45 µM). This ﬁltering technique traps bacte-
ria on the ﬁlter. The ﬁlter can then be cultured on selective
media and enumeration can be done.[6]
The classical methods used have several advantageous
and disadvantageous characteristics. For instance, the290 Hendricks and Pool
MTF method allows for semi-quantitative enumeration of
coliforms but is labour intensive. The MTF method is also
time consuming and a subculture stage for conﬁrmation is
needed.[6]
Chromogenic tests to monitor total coliforms and E. coli
are commercially available. Chromogenic tests are effective
andareabletodetecttotalcoliformsandE.coli indifferent
water sources. In addition, these tests take advantage of
enzymatic properties of coliforms. These tests are speciﬁc
and only total coliforms and E. coli that feed on deﬁned
substrate nutrients in the medium can release a chromogen
or ﬂuorochrome. Chromogen or ﬂuorochrome production
indicates the presence of the microbes.[6] These tests are
easy and rapid to use and can save on costs.[6]
Modern disease management strategies have resulted in
increased pharmaceutical use, particularly the use of an-
tibiotics. Additionally, antibiotics are also used in veteri-
nary medicine.[7] In humans and animals, antibiotics exit
via urine or faeces. Antibiotics are not always metabolized
and a large amount of biologically active ingredients are
discharged with urine and faeces. These unchanged or par-
tially metabolized antibiotics then enter sewage where it
may either be eradicated by sewage treatment processes
or released with sewage efﬂuents into the aquatic envi-
ronment.[7] Antibiotic residues in the environment could
elicit potential adverse consequences such as bacterial re-
sistance. Moreover, antibiotics and their metabolites could
displaysynergismoradditionalunintendedeffectsandpose
a health risk to aquatic species and consumers of the con-
taminated water.[8]
The 4-Quinolones and synthetic pharmaceuticals such
as ﬂuoroquinolones, quinolones and quinolone carboxylic
acids are used extensively as antibiotics in human and
veterinary medicine.[9] Fluoroquinolones have a broad
spectrum of activity and enhanced pharmokinetic prop-
erties.[10] Some of the ﬂouroquinolone antibiotics include
ciproﬂoxacin, oﬂoxacin, levoﬂoxacin and norﬂoxacin.[10]
Fluoroquinolones have been found in raw and treated
sewage efﬂuents.[11,12] The release of ﬂuoroquinolones
into the environment can have adverse effects on aquatic
microorganisms.[13]
The sulphonamides are components of sulfanilamide.[14]
One of the sulphonamide antibiotic residues includes sul-
famethoxazole. Sulfamethoxazole is used extensively as an
antimicrobial in animals and humans.[15] Sulfamethoxole
can be discharged into the environment, via sewage efﬂu-
ents, where it remains persistent.[16]
Many countries are monitoring the presence, removal
and fate of contaminants in raw wastewater and treated
sewage efﬂuents.[17,18] In South Africa several studies have
focussed on the presence of bacteria in sewage efﬂu-
ents.membranebioreactorplantsarehigherLittleisknown
about other contaminants in wastewater and treated efﬂu-
ents from sewage treatment plants in South Africa. The
National Water Act of South Africa (Act no. 36 of 1998)
consistsofseveralchapters.Inparticular,Chapter3,Part4,
dealswithpollutionprevention.Certainrequirementsneed
tobeimplementedbytheownerofthepropertieswhereac-
tivities or processes occur that can result in pollution of a
water source. Measures include containing and preventing
the release of pollutants into the environment, eliminating
any sources of pollutants and to remedy the effects of the
pollution.
The South African constitution also has several acts that
pertain to environmental rights. Section 24 (a) states that:
“Every human has the right to an environment that is not
harmful to human health or well-being.” The constitution
further states in Section 24 (b) that: “Everyone has the
right to have the environment protected.” Water is a scarce
commodity and needs to be protected to ensure sustain-
able usage. The aim of this study was to determine the oc-
currence of faecal bacteria, and antibiotic residues in raw
and treated sewage efﬂuents from three different sewage
treatment plants in the Western Cape, South Africa. Co-
liforms and E.coli were used as bioindicators for faecal
bacteria. Fluoroquinolone and sulfamethoxazole are com-
monly used antibiotics and were used to monitor the efﬁ-
ciency of sewage plants to remove antibiotics.
Materials and methods
Site description and water collection
Rawwastewaterandtreatedsewageefﬂuentswerecollected
from three different sewage treatment plants in the West-
ern Cape, South Africa. The treatment plants investigated
are on the same river system. Sewage treatment plant 1
and 2 use older technologies to treat wastewater. Sewage
treatment 3 has been upgraded and new technologies were
incorporated in the treatment processes. Sewage treatment
plant 2 and 3 receives domestic efﬂuents only. However,
sewage treatment plant 1 receives both domestic (85% ﬂow
intake) and industrial raw wastewater (15% ﬂow intake).
A detailed description of sewage treatment technologies
forthedifferentsewagetreatmentplantsareasfollows.The
older technologies used at the sewage treatment plants can
be divided into three processes, namely:
(i) Primary treatment which includes pre-treatment of
raw wastewater intake by coarse and ﬁne screens for
grit removal. This process uses sedimentation tanks to
allow the heavier organic particles to settle.
(ii) Secondary treatment of raw water using activated
sludge. This process uses aerated biological diges-
tion by bacteria to remove remaining suspended and
dissolved material. In addition, nitriﬁcation and de-
nitriﬁcation of wastewater is also used as treatment
processes within the sewage treatment plants. There-
after, the wastewater enters the secondary sedimenta-
tion tank to allow separation of the liquid and solid
phase. After secondary sedimentation the wastewater
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(iii) Tertiary treatment is the ﬁnal step in the conventional
activatedsludgesystemusedbysewagetreatmentplant
1 and 2. Ultraviolet light (used only at sewage treat-
ment plant 1) or chlorine (used only at sewage treat-
ment plant 2) are the disinfection processes used,
before the treated sewage efﬂuent are released from
plants.
Sewage treatment plant 3 uses an additional treatment
technology (membrane bioreactor) concurrently with con-
ventional or older treatment technologies. The membrane
bioreactortechnologyconsistsofmicroporousmembranes.
These micro-ﬁltration and ultra-ﬁltration membranes sep-
arate liquid and solids.
Water collected from the Eerste River in Jonkershoek,
Stellenbosch, South Africa was used as a negative control.
This site is situated in the Stellenbosch mountains, and
thereisnohumanactivityupstreamfromthisarea.Samples
were collected in pre-cleaned 1 Liter (1 L) plastic bottles
and transported to the laboratory in a cooler.
Monitoring of total coliforms and E.coli in wastewater
samples
Raw wastewater and treated sewage efﬂuents from all
sewage treatment plants were collected over a four week
sampling period. Total coliforms and E. coli in wastewater
samples were monitored by using the Readycult Coliforms
100 (Merck, Germany). The test was performed accord-
ing to the manufacturer’s instructions. The Readycult
Coliforms 100 is a chromogenic test that simultaneously
detects total coliforms and E. coli. Tests for total coliforms
and E.coli were done using 10 mL, 1 mL or 0.1 mL of
water samples. Raw wastewater and treated sewage efﬂuent
samples were incubated overnight at 37◦C, before analysis.
Coliforms are indicated by a yellow to blue-green colour
change of medium, while ﬂuorescence under U.V. light is
indicative of E. coli in the sample.
Solid-phase extraction of water samples
Samples were ﬁltered with ﬁlter paper (Munktell, 15 µM,
240mm)(Lasec,SA)beforeextraction.Watersampleswere
then extracted using C-18 columns (Sigma Aldrich, South
Africa). Columns were conditioned with 2 mL of Phase B
mixture (45% methanol, 40% hexane and 15% propanol),
then 2 mL ethanol and lastly 4 mL distilled water. After the
washing step, 100 mL of water sample was passed through
the column.
The columns were then dried using a vacuum pump
(PALL vacuum pump, LifeSciences, 60 Hz, 1.92 Amperes,
220–240 Volts). The hydrophobic analytes attached to the
resin were eluted with 2 mL of Phase B mixture. The elu-
ates were dried under a stream of air. The dried eluate was
reconstituted with dimethyl sulfoxide (DMSO) to make a
1000 times concentrated sample stock solution. Extracts
were diluted in 10% methanol at a ratio of 1:100 for the
ﬂuoroquinolone ELISA.
Fluoroquinolone analysis of raw and ﬁnal treated
wastewater extracts
Fluoroquinolone ELISA kits were purchased from
Abraxis, Warminister, PA. Samples were analyzed accord-
ing to the instructions included in the kit. All reagents
required were supplied in the kit. The ELISA plate was
precoated with antibodies speciﬁc to a unique antigenic
siteontheﬂuoroquinolonemolecule.Samplesorstandards
and ﬂuoroquinolone enzyme conjugate were pre-mixed in
an uncoated microplate (100 µL of each solution).
Thereafter, 100 µL of the pre-mixture was transferred
per well of the coated plate. The plate was then incubated
for 1 hour at room temperature. Thereafter, the wells were
washed ﬁve times with wash solution and tapped dry. After
washing, 100 µLof substrate was added to all wells and in-
cubated for 30 minutes at room temperature. The enzyme
reaction was stopped by adding 100 µL of stop solution
to all wells. The optical density was read at 450 nM with
a microtiter plate reader (Thermo Electron Corporation,
Original Multiskan Ex). The 0 µg/L standard results in
maximum binding of the enzyme conjugate. All data was
expressed as a percentage of 0 µg/L standard. A stan-
dard curve was drawn using the results obtained for the
standards and the concentrations of the samples were read
from this curve.
Sulfamethoxazole analysis of raw and ﬁnal wastewater
Rawwastewaterandtreatedsewageefﬂuentsweresterilized
with 0.45 µM sterile ﬁlters (Lasec, SA) prior to use in the
Sulfamethoxazole ELISA. Sulfamethoxazole ELISA kits
were purchased from Abraxis, Warminister, PA. Samples
were analyzed according to the instructions included in
the kit. All reagents required were supplied in the kit. The
ELISA plate was precoated with antibodies speciﬁc to a
unique antigenic site on the sulfamethoxazole molecule.
Samples or standards were added to the precoated
microplate (75 µL/well). Thereafter, 50 µL/well of the
anti-sulfamethoxazole antibody solution was added to the
microplate. The contents of the wells were then mixed for
20–30 seconds. After mixing, the plate was incubated at
room temperature for 20 minutes.
After the incubation period, 50 µL/well of the sul-
famethoxazole enzyme conjugate solution was added to
each well of the microplate. After mixing as before, the
plates were then incubated for 40 minutes at room temper-
ature. Thereafter, the wells were washed four times with
wash solution and tapped dry. After washing, 150 µLo f
substrate solution was added to all wells and incubated for
30 minutes at room temperature. The enzyme reaction was
stopped by adding 100 µL of stop solution to all wells. The
optical density was then read at 450 nm with a microtiter292 Hendricks and Pool
Table 1. Detection of total coliforms and E. coli in raw wastewater and treated sewage efﬂuents from three sewage treatment plants
in the Western Cape, South Africa.
Week 1 Week 2 Week 3 Week 4
Sample name Sample vol. (mL) Coliforms E. coli Coliforms E. coli Coliforms E. coli Coliforms E. coli
Jonkershoek (control site) 10 Y N Y N Y N Y N
1 NNNNNNNN
0 . 1 NNNNNNNN
STP 1 Domestic Raw water 10 Y Y Y Y Y Y Y Y
1 YYYYYYYY
0 . 1 YYYYYYYY
STP 1 Industrial Raw water 10 Y Y Y Y Y Y Y Y
1 YYYYYYYY
0 . 1 YYYYYYYY
STP 1 Treated sewage efﬂuent 10 Y Y Y Y Y Y Y Y
1 YYYYYYYY
0 . 1 YYYYYYYY
S T P 2 R a w w a t e r 1 0 YYYYYYYY
1 YYYYYYYY
0 . 1 YYYYYYYY
S T P 2 T r e a t e d s e w a g e e f ﬂ u e n t 1 0 NNNNNNNN
1 NNNNNNNN
0 . 1 NNNNNNNN
S T P 3 R a w w a t e r 1 0 YYYYYYYY
1 YYYYYYYY
0 . 1 YYYYYYYY
S T P 3 T r e a t e d s e w a g e e f ﬂ u e n t 1 0 YNYNYNYN
1 NNNNNNNN
0 . 1 NNNNNNNN
platereader(ThermoElectronCorporation,OriginalMul-
tiskan Ex). The 0 µg/L standard results in maximum bind-
ing of the enzyme conjugate. All data was expressed as
a percentage of 0 µg/L standard. A standard curve was
drawn using the results obtained for the standards and the
concentrations of the samples were read off this curve.
Statistical analysis
One way analysis of variance (ANOVA) was used to com-
pare results for the antibiotic assays, with P < 0.050 con-
sidered as signiﬁcant. Statistical analysis was done using
SigmaPlot Version 11.
Results
The detection of total coliforms and E. coli
The Readycult Coliforms 100 is a chromogenic test that
simultaneously detects total coliforms and E.coli. A yellow
toagreen-bluecolourchangeoftheculturebrothindicated
the presence of total coliforms. Fluorescence of the broth
under ultraviolet light indicated the presence of E. coli.
Conﬁrmation of the presence of E. coli was further done
by addition of Kovac’s reagent (Merck, Germany) to the
broth. Table 1 shows the recovery of total coliforms and E.
coli in raw wastewater and treated sewage efﬂuents from all
sewage treatment plants over the 4-week sampling period.
For the Jonkershoek negative control sample 1-10
CFU/100 mL of total coliforms was detected at each of
the collection times. However, E. coli was not found in the
Jonkershoek negative control samples. All the raw wastew-
ater samples tested positivewith morethan1000 CFU/100
mL total coliforms and E. coli detected.
Total coliforms and E. coli were detected at levels more
than 1000 CFU/100 mL in treated sewage efﬂuent for
sewage treatment plant 1. The total coliforms and E. coli
levels in treated sewage efﬂuents from sewage treatment
plant2werelessthan1CFU/100mL.Totalcoliformswere
detected at 1–10 CFU/100 mL in treated sewage efﬂuents
from sewage treatment plant 3. This is similar to the levels
found in the Jonkershoek negative control water sample.
The E. coli levels in treated sewage efﬂuents produced by
sewage treatment plant 3 were less than 1 CFU/100 mL.
Detection of ﬂuoroquinolones in raw wastewater and treated
sewage efﬂuents from the three sewage treatment plants
Raw wastewater and treated sewage efﬂuents from all
sewage treatment plants were analysed for the presence
of ﬂuoroquinolones. Results for the detection of ﬂuoro-
quinolones in raw wastewater and treated sewage efﬂuents
from all sewage treatment plants are illustrated in Tables 2,Effectiveness of sewage treatment processes 293
Table 2. Mean concentration (ng/L ± SD) of selected antibiotics found in domestic and industrial raw wastewater and treated sewage
efﬂuents for sewage treatment plant 1 (n = 8).
Sewage treatment plant 1
Jonkershoek
negative control
Domestic raw
wastewater
Industrial raw
wastewater
Calculated value
of mixture
Treated sewage
efﬂuents
Percentage
reduction (%)
Fluoroquinolones (ng/L) 2±29 0 ±24a 89±28a 90±19a 92±29a 2±10
Sulfamethoxazole (ng/L) 0±0 111±0a 156±12a 118±3a 121±28a 4±1
aStatisticallydifferenttonegativecontrol(P<0.050).Sewagetreatmentplant1usestheconventionalactivatedsludgesystemaswastewatertreatment
processes.
Table 3. Mean concentration (ng/L ± SD) of selected antibiotics found in raw wastewater and treated sewage efﬂuents for sewage
treatment plant 2 (n = 8).
Sewage treatment plant 2
Jonkershoek negative
control Raw wastewater
Treated sewage
efﬂuents Percentage reduction (%)
Fluoroquinolones (ng/L) 2±29 2 ±11a 72±34a 21±5
Sulfamethoxazole (ng/L) 0±0 153±7ab 101±44a 34±9
aStatistically different to negative control (P < 0.050).
bStatistically different to treated sewage efﬂuents (P < 0.050).
Sewage treatment plant 2 uses the conventional activated sludge system as wastewater treatment processes.
3, and 4, respectively. Concentrations of ﬂuoroquinolones
are represented as Mean ng/L ± Standard deviation (SD).
The percentage reduction of ﬂuoroquinolones from raw
wastewater to treated sewage efﬂuents are also given in the
tables. Very low or undetectable levels of ﬂuoroquinolones
were found in the Jonkershoek negative control.
Fluoroquinolones detected in the domestic and indus-
trial raw wastewater from sewage treatment plant 1 were 90
± 24 ng/L and 89 ± 28 ng/L, respectively (Table 2). The
combined concentration of ﬂuoroquinolone for the mix-
tureofdomesticandindustrialrawwastewaterfromsewage
treatment plant 1 was 90 ± 19 ng/L. Fluoroquinolone
concentrations in domestic and industrial raw wastewater
and the combined mixture concentration was higher when
compared to the Jonkershoek negative control (P < 0.050).
Fluoroquinolone concentration in treated sewage efﬂuents
from sewage treatment plant 1 was 92 ± 29 ng/L.
There was no difference in the ﬂuoroquinolone con-
centration of the domestic raw wastewater, industrial raw
wastewater, the combined mixture and treated sewage ef-
ﬂuents from sewage treatment plant 1. Fluoroquinolone
concentration in the treated sewage efﬂuents was signiﬁ-
cantly higher compared to the Jonkershoek negative con-
trol (P < 0.050). The conventional activated sludge process
at sewage treatment plant 1 reduced the ﬂuoroquinolone
concentration by 2%.
Fluoroquinoloneconcentrationsdetectedinrawwastew-
ater from sewage treatment plant 2 was 92 ± 11 ng/L
(Table 3). Fluoroquinolone concentrations in the raw
wastewater were higher when compared to the Jonker-
shoek negative control (P < 0.050). Fluoroquinolone
concentration in treated sewage efﬂuents from sewage
treatment plant 2 was 72 ± 34 ng/L. There was no
difference in the ﬂuoroquinolone concentration of the
raw wastewater and treated sewage efﬂuents from sewage
treatment plant 2. Fluoroquinolone concentrations in the
treated sewage efﬂuents was signiﬁcantly higher compared
to the Jonkershoek negative control (P < 0.050). The
Table 4. Mean concentration (ng/L ± SD) of selected antibiotics found in raw wastewater and treated sewage efﬂuents for sewage
treatment plant 3 (n = 8).
Sewage treatment plant 3
Jonkershoek negative
control Raw wastewater
Treated sewage
efﬂuents Percentage reduction (%)
Fluoroquinolones (ng/L) 2±29 9 ±11a 68±33a 31±3
Sulfamethoxazole (ng/L) 0±0 170±4ab 76±23a 56±9
aStatistically different to negative control (P < 0.050).
bStatistically different to treated sewage efﬂuents (P < 0.050).
Sewage treatment plant 3 uses the newer membrane technology as an additional wastewater treatment process.294 Hendricks and Pool
conventional activated sludge process at sewage treatment
plant2reducedtheﬂuoroquinoloneconcentrationby21%.
Fluoroquinoloneconcentrationsdetectedinrawwastew-
ater from sewage treatment plant 3 was 99 ± 11 ng/L
(Table 4). Fluoroquinolone concentrations in the raw
wastewaterwerehigherwhencomparedtotheJonkershoek
negative control (P < 0.050). Fluoroquinolone concentra-
tionintreatedsewageefﬂuentswas68±33ng/L.Therewas
no difference in the ﬂuoroquinolone concentration of raw
wastewater and treated sewage efﬂuents from sewage treat-
mentplant3.Fluoroquinoloneconcentrationinthetreated
sewage efﬂuents was signiﬁcantly higher compared to the
Jonkershoek negative control (P < 0.050). The membrane
bioreactor process at sewage treatment plant 3 reduced the
ﬂuoroquinolone concentration by 31%.
Detection of sulfamethoxazole in raw wastewater and
treated sewage efﬂuents from the three sewage treatment
plants
Raw wastewater and treated sewage efﬂuents from all
sewage treatment plants were analysed for the presence of
the antibiotics sulfamethoxazole. Results for the detection
of sulfamethoxazole in raw wastewater and treated sewage
efﬂuents in all sewage treatment plants are illustrated in
Tables 2, 3, and 4, respectively. Concentrations of sul-
famethoxazole are represented as Mean ng/L ± Standard
deviation (SD). The percentage reduction of sulfamethox-
azole from raw wastewater to treated sewage efﬂuents are
also given in the tables. Very low or undetectable levels of
sulfamethoxazole were found in the Jonkershoek negative
control.
Sulfamethoxazole detected in the domestic and indus-
trial raw wastewater from sewage treatment plant 1 were
111 ± 4 ng/L and 156 ± 12 ng/L, respectively (Table
2). The combined concentration of sulfamethoxazole for
the mixture of domestic and industrial raw wastewater
from sewage treatment plant 1 was 118 ± 3 ng/L. Sul-
famethoxazole concentrations in domestic and industrial
rawwastewater,andthecombinedmixturewashigherwhen
compared to the Jonkershoek negative control (P < 0.050).
Sulfamethoxazoleconcentrationintreatedsewageefﬂuents
from sewage treatment plant 1 was 121 ± 28 ng/L. There
was no difference in the sulfamethoxazole concentration
of the domestic raw wastewater, industrial raw wastewater
and treated sewage efﬂuents of sewage treatment plant 1.
Sulfamethaxole concentrations in the treated sewage efﬂu-
ents was signiﬁcantly higher compared to the Jonkershoek
negative control (P < 0.050). The conventional activated
sludge process at sewage treatment plant 1 reduced the sul-
famethoxazole concentration by 4%.
Sulfamethoxazoleconcentrationdetectedinrawwastew-
ater from sewage treatment plant 2 was 153 ± 7n g / L
(Table 3). Sulfamethoxazole concentrations in the raw
wastewater was higher when compared to the Jonkershoek
negative control (P < 0.050). Sulfamethoxazole concentra-
tionintreatedsewageefﬂuentsfromsewagetreatmentplant
2 was 101 ± 44 ng/L. Sulfamethoxazole concentrations in
raw wastewater was signiﬁcantly higher than levels found
in the treated sewage efﬂuents for sewage treatment plant
2( P < 0.050). Sulfamethaxole concentration in the treated
sewage efﬂuents was signiﬁcantly higher compared to the
Jonkershoek negative control (P < 0.050). The conven-
tional activated sludge process at sewage treatment plant 2
reduced the sulfamethoxazole concentration by 34%.
Sulfamethoxazoleconcentrationdetectedinrawwastew-
ater from sewage treatment plant 3 was 170 ± 4n g / L
(Table 4). Sulfamethoxazole concentrations in the raw
wastewater was higher when compared to the Jonkershoek
negative control (P < 0.050). Sulfamethoxazole concentra-
tion in the treated sewage efﬂuents from sewage treatment
plant 3 was 76 ± 23 ng/L. Sulfamethoxazole concentra-
tions in raw wastewater was signiﬁcantly higher than levels
found in the treated sewage efﬂuents for sewage treatment
plant 3 (P < 0.050). Sulfamethaxole concentration in the
treated sewage efﬂuents was signiﬁcantly higher compared
to the Jonkershoek negative control (P < 0.050). The
membrane bioreactor process at sewage treatment plant 3
reduced the sulfamethoxazole concentration by 56%.
Discussion
Treated sewage efﬂuents containing residual pollutants are
often dishcarged into surface water. These efﬂuents can
contributetothepathogensintheenvironment.[22]Agr oup
ofbacteria,knownasthecoliformsareusedtomonitorthe
microbiological quality of water.[23] The occurrence of non
pathogenic faecal coliforms in water can indicate the oc-
currence of pathogenic microorganisms that are of faecal
origin.[23] One of the main bacterial indicators of faecal
contamination is E. coli.[24] Studies have shown that gas-
trointestinal and respiratory diseases are linked to polluted
watersthathaveincreasednumbersofindicatorbacteria.[25]
Monitoring the bacteriological quality of water is an im-
portant parameter to limit these diseases.
In this study, total coliforms and E. coli were detected
in raw wastewater from all sewage treatment plants. Since
wastewater from homes, hospitals and commercial build-
ings collects in sewers and ﬂows to sewage treatment
plants, high faecal bacteria counts were expected in the
raw sewage.[19]
High loads of total coliforms and E. coli present in
treated sewage efﬂuents from sewage treatment plant 1,
show that the treatment processes and disinfection by the
UVlightatthisplantareineffectiveinremovingfaecalbac-
teria.Themaximumfornoriskis0CFU/100mLforfaecal
coliformsand10CFU/100mLfortotalcoliforms.[26]Con-
sequentlytheseguidelinessetout(1998)bytheDepartment
ofWaterAffairsandForestyofSouthAfricaimplythatthe
treated sewage efﬂuents from sewage treatment plant 1 is
of poor microbiological quality.[26] The results of this study
conﬁrm data obtained in previous studies that have shownEffectiveness of sewage treatment processes 295
that U.V. light disinfection of sewage efﬂuent does not re-
duce microbial populations as effectively as disinfection by
chlorine.[27]
Treatment technologies employed by sewage treatment
plant2issimilartothatofsewagetreatmentplant1,except
at the tertiary treatment where chlorination is used instead
of UV disinfection. The treated sewage efﬂuents produced
by sewage treatment plant 2 was of acceptable microbio-
logical quality with both total coliforms and E.coli below
the recommended levels. However, studies have shown that
other properties play a role in treatment of wastewater.
Conductivity, pH, dissolved oxygen, nitrogen and phos-
phate content may have an effect on bacterial communities
presentinsewage.[19,28]Sewageefﬂuenttreatmentwithchlo-
rine may have adverse effects on aquatic life. Chlorination
results in the formation of some toxic by-products forma-
tionandthesecanhaveadverseeffectsontheaquaticlife.[29]
E. coli was not detected in treated sewage efﬂuents from
sewage treatment plant 3. This therefore implies that the
membrane bioreactor technology employed by the plant
was effective in removing E. coli from sewage. These re-
sults are consistant with studies that showed high removal
rates of E. coli from sewage upon membrane bioreactor
treatment.[30]
The global consumption of antimicrobials is estimated
to be between 100,000 and 200,000 tons per year.[31]
The occurrence of pharmaceuticals in raw wastewater is
dependant on different factors.[11] For instance, the total
consumption of antibiotics by different populations and
countries may vary.
Fluoroquinolones are the most widely prescibed antibi-
otics.[10] Results of this study shows that these antibiotics
are extensively used in South Africa and high levels of
the antibiotics are present in sewage. Fluoroquinolones
were detected in all raw wastewater samples. The levels
detected ranged from 89 ng/L to 92 ng/L. Seasonal
variations in antibiotic levels in sewage can occur. During
winter months people are more likely to become sick and
therefore increased levels of antibiotics are prescribed.
Castiglioni et al.[32] has shown that antibiotic use in winter
is considerably more than in summer. However, the levels
of antibiotics can differ between sewage treatment plants
at different time periods.[33]
This study shows that ﬂuoroquinolones were not ef-
fectively eliminated by the treatment processes at the
three sewage treatment plants investigated (Tables 2, 3, 4).
Treated sewage efﬂuents contained signiﬁcantly higher ﬂu-
oroquinolones than the Jonkershoek negative control site
(P < 0.050). No signiﬁcant difference in ﬂuoroquinolone
concentrationsbetween raw wastewater and treated sewage
efﬂuents were found, indicating that sewage treatment pro-
cesses used by the three plants are inefﬁcient at removing
thisantibioticfromsewage.Theresultsshowthathighloads
of ﬂuoroquinoloes are discharged into the environment.
The results of this study are consistent with previous
studies that showed high levels of ﬂuoroquinolones in ef-
ﬂuents from sewage treatment plants.[34] Fluoroquinolones
have been measured in sewage treatment plant efﬂuents
in European countries such as France (300–500 ng/L);
Italy (300–500 ng/L); Greece (500 ng/L) and Switzerland
(30–1100 ng/L).[34] The current study shows that the ﬂu-
oroquinolone concentrations in the sewage efﬂuents from
the three sewage treatment plants investigated are similar
to levels in Switzerland.
The type of treatment technology used may aid in the
removal of antibiotics from wastewater.[35] In this study
sewage treatment plant 1 and 2 use the conventional ac-
tivated sludge process only for treatment. In addition to
the conventional activated sludge process, sewage treat-
ment plant 3 also use membrane bioreactor technology
for sewage treatment. The percentage reduction of ﬂuoro-
quinolones differed according to the sewage treatment pro-
cesses used. A 2% and 21% reduction of ﬂuoroquinoloes
for the conventional activated sludge processes at sewage
treatment plant 1 and 2 were calculated. For the membrane
bioreactor technology at sewage treatment plant 3, a cal-
culated value of 31% was found. These results indicate that
despite the different treatment technologies used, elimina-
tion of the ﬂuoroquinolones from treated sewage efﬂuents
are minimal.
The nature of the drug also plays a role in its re-
moval from wastewater. The ﬂuoroquinolone antibiotics
are very hydrophilic compounds.[11] Elimination of ﬂuo-
roquinolones is mainly via sorption to sludge.[12] In con-
trast, other studies have shown high removal rates of ﬂu-
oroquinolones from wastewater.[8] However, this was not
evident in this study.
Severalotherfactorsneedtobetakenintoconsideration.
Studies have suggested that the dilution of raw wastewater
by heavy rain can result in the reduction of pharmaceuti-
cal removal by sewage treatment plants.[17] Other factors
such as temperature of the wastewater, the hydraulic and
solid rentention time, age of the activated sludge, environ-
mental conditions and characterstics of the raw inﬂuent
may all play a role in the elimination of pharmaceuticals
in wastewater.[11,40] Discharge of these compounds to re-
ceiving waters can result in adverse effects to ﬁsh species
and an eventual health risk to consumers of ﬁsh caught in
contaminated water bodies.[36,37]
Sulfamethoxazole is an antibiotic used widely in hu-
man and veterinary medicine.[14] Sulfamethoxazole is re-
sistant to breakdown and has been found in environmen-
tal ecosystems.[38,39] Sulfamethoxazole was detected in all
raw wastewater samples analysed in this study (Tables 2,
3, 4). The sulfamethoxazole concentration of the treated
sewage efﬂuents were signiﬁcantly higher than the Jonker-
shoek negative control (P < 0.050), indicating incomplete
removal during sewage treatment processes. Sewage treat-
ment plant 1 did not reduce the sulfamethoxazole concen-
tration and the antibiotic was released at very high levels
in the treated sewage efﬂuents. These results are similar to
those published by Zuccato et al.[40] A signiﬁcant decrease296 Hendricks and Pool
of sulfamethoxazole concentration in treated sewage efﬂu-
ents compared to raw wastewater can be seen for sewage
treatment plant 2 and 3 (P < 0.050).
The percentage reduction of sulfamethaxazole for
sewage treatment plant 2 and 3 was 34% and 56%, respec-
tively.Watkinsonetal.[41]hasshownthatthemeanremoval
rate of sulfamethoxazole in conventional activated sludge
plantswas92%;however,concentrationsintheng/L range
are still present in treated sewage efﬂuents. In contrast, re-
moval rates of sulfamethoxazole in membrane bioreactor
plants are higher.[42]
Conclusion
The present study indicated the occurrence of faecal bacte-
riainrawwastewaterandtreatedsewageefﬂuentsfromcer-
tain sewage treatment plants. UV light disinfection showed
inefﬁcientremovaloffaecalbacteriacomparedtochlorina-
tion. Newer technologies such as the membrane bioreactor
technology in sewage treatment plant 3 reduced the faecal
bacteria in treated sewage efﬂuents. However, other factors
such as pH and conductivity of wastewater may play a role
in bacterial communities that survive.
The results of this study also show that due to inefﬁcient
removal by treatment processes, antibiotic residues are still
present in treated sewage efﬂuents. Therefore, wastewater
with high raw inﬂuent concentrations of antibiotics will
require some form of additional treatment to reduce their
concentration in treated sewage efﬂuents. This study also
showedthatmembranebioreactortechnologycouldpoten-
tially be helpful in reducing the amount of contaminants
released into the environment.
The National Water Act of SA (Act no. 36 of 1998)
needs to be strictly enforced by government to ensure the
conservation of our water sources. Further research needs
tobeundertakentoimprovesewagetreatmenttechnologies,
thereby producing a better quality treated sewage efﬂuent.
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